Oncternal Therapeutics, Inc. Annual Operating Margin in % from 2010 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Oncternal Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2010 to 2023.
  • Oncternal Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -2.04K %, a 60.9% increase year-over-year.
  • Oncternal Therapeutics, Inc. annual Operating Margin for 2023 was -5.31K %, a 76.2% decline from 2022.
  • Oncternal Therapeutics, Inc. annual Operating Margin for 2022 was -3.02K %, a 315% decline from 2021.
  • Oncternal Therapeutics, Inc. annual Operating Margin for 2021 was -727 %, a 39.9% decline from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -5.31K -2.3K -76.2% Jan 1, 2023 Dec 31, 2023
2022 -3.02K -2.29K -315% Jan 1, 2022 Dec 31, 2022
2021 -727 -207 -39.9% Jan 1, 2021 Dec 31, 2021
2020 -520 +846 +61.9% Jan 1, 2020 Dec 31, 2020
2019 -1.37K -1.06K -354% Jan 1, 2019 Dec 31, 2019
2018 -301 Jan 1, 2018 Dec 31, 2018
2011 -244 -268 -1078% Jan 1, 2011 Dec 31, 2011
2010 24.9 Jan 1, 2010 Dec 31, 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.